Postpartum Hair Loss Treatment While Breastfeeding: The Risks of Each Option
What each postpartum hair loss option puts into your body and your breast milk, and what the evidence says it does for hair: finasteride, minoxidil, biotin, hair supplements, and red light caps, side by side.
Key takeaways
- Postpartum shedding ends on its own, and no treatment has been tested in a placebo-controlled trial on new mothers shedding after having a baby.
- Finasteride is not for women who could become pregnant, and in the one large trial in women it did no better than a placebo.
- Minoxidil has the best hair recovery evidence in women, but breastfeeding sources disagree about it, and any form of the drug will reach your blood.
- Popular hair supplements lack good evidence that they help hair recovery, and some of their ingredients are best avoided while nursing.
- A red light therapy cap is the only option that puts nothing into your body and has evidence in placebo-controlled trials for supporting hair recovery (in pattern hair loss).
Short answer: when you swallow a pill or rub a drug onto your scalp while breastfeeding, some of it can potentially reach your blood and, from there, your milk. That possibility is the main risk to weigh with any treatment for postpartum hair loss. Minoxidil, finasteride, biotin, and other hair supplements all add something to your body, so each one carries that risk to some degree. A red light therapy cap is the only option that puts nothing into your body.
Considerations before choosing an approach
Postpartum shedding usually ends around month 8, with your hair starting to recover normal fullness within 12 months (the full timeline). The American Academy of Dermatology (AAD) says it is "temporary, and you do not have to do anything to remedy it."
No treatment of any kind, red light or supplements, has been tested in a placebo-controlled trial on mothers' shedding after having a baby. All the hair recovery results on this page come from studies of pattern hair loss - the hereditary kind that shows up over time.
So the decision is whether you want to try to speed up your recovery. For most moms, that depends on how severe the shedding is. In the largest survey of postpartum shedding, more than half of mothers (61%) said they lost "quite a lot" of hair or "very much."
Common options
For breastfeeding advice we used LactMed, the NIH's database on medicines and breastfeeding, and a 2025 review of hair-loss treatments while breastfeeding from NYU's dermatology department. Where these are silent or split, we also checked e-lactancia, an online breastfeeding compatibility database.
| Option | Does it help with hair recovery? | Puts something into your body? | What breastfeeding sources say |
|---|---|---|---|
| Finasteride (pill) | Works in men, but no better than a placebo in a trial of women | Yes, but unknown if it reaches milk | Avoid: not recommended while nursing, and never if you may become pregnant |
| Minoxidil pill | Used off-label in low doses for pattern hair loss | Yes, and it can be measured in breastmilk | Use with caution, if at all; its label says not to use it while nursing |
| Minoxidil rub-on (Rogaine) | Yes, in women with pattern hair loss | Yes, and it can be measured in blood, and it can rub off on your baby | Use with caution, if at all; its label warns it may be harmful while breastfeeding |
| Biotin | No good evidence of effectiveness unless you are low on biotin | Yes, and in high doses it can throw off blood tests | Considered compatible |
| Other hair supplements | No good evidence. Nutrafol Postpartum's studies in new moms were self-rated | Yes, usually several ingredients at once | Some common ingredients are best avoided while nursing |
| Red light therapy cap | Yes, in pattern hair loss | No. Only light on your scalp | Acceptable while nursing |
Finasteride: not for women who could become pregnant
Finasteride works for men, which is why it comes up. Its FDA label says it treats male pattern hair loss in men only, and that it "is not indicated for use in women." In women, the evidence for hair recovery is weak. In a year-long trial of 137 postmenopausal women with pattern hair loss, finasteride did no better than a placebo.
Women who are or may become pregnant must not use it, because it can harm the genitals of a male baby in the womb. The AAD says a dermatologist may prescribe it to a woman with hereditary hair loss who "cannot get pregnant."
Breastfeeding is a separate question. The 2025 NYU review lists finasteride as not recommended while breastfeeding, with more data needed, and the label says it is not known whether finasteride passes into milk.
Minoxidil: real evidence, real risks, mixed advice
Minoxidil is the drug in Rogaine, and it has the best hair recovery evidence for women of any drug on this page. However, advice for new mothers varies, depending on the source your doctor follows.
- Pill. Minoxidil pills are FDA-approved only for severe high blood pressure, and their label says the drug "should not be administered to a nursing woman." Dermatologists who use it to treat hair loss prescribe low doses off-label for pattern hair loss. LactMed reports that the drug can be measured in breast milk, and it says to use the pill "with caution," especially with a newborn. And a 2025 NYU dermatology review advised caution because the drug may pass to the baby through milk, especially to a premature or newborn baby.
- Rub-on. The label on women's Rogaine foam says the foam "may be harmful if used when pregnant or breast-feeding," without saying what the harm would be, and not to use it if "your hair loss is associated with childbirth." A measurable amount has been shown to reach your blood: about 1.4% of what you put on your skin, according to e-lactancia. And a 2025 NYU dermatology review advised caution because the drug may pass to the baby through skin contact or milk, especially to a premature or newborn baby. Even so, some sources think it might be acceptable while breastfeeding, with LactMed saying that it is "acceptable once breastfeeding is established," but to keep your baby off treated skin.
Popular hair supplements: little evidence, potential risks
Biotin pills have not been shown to help with hair loss unless you are already low on biotin, which the AAD says is rare. Low biotin can cause hair loss, but a 2019 review found "no evidence-based data that supplementing biotin promotes hair growth," and a 2024 review, which found only three studies of biotin pills for hair loss, agreed. High doses can also throw off lab results, "particularly for hormone tests like thyroid levels," according to the AAD. For breastfeeding, e-lactancia rates biotin as compatible, even at a high dose of 2.5 mg a day, and LactMed has no entry for it.
Nutrafol Postpartum, the supplement most moms hear about, has been examined in two studies in new moms sponsored by Nutrafol. Both studies measured how moms rated their own hair regrowth, with no placebo group or objective measurement described. This is a challenging study setup as self-rating is unreliable and postpartum hair regrows on its own, making it difficult to tell whether the supplement was actually effective. Nutrafol Postpartum is sold as "breastfeeding friendly," but it also contains theanine, which LactMed says is "probably best to avoid" while nursing a newborn or preterm baby.
If you do opt to take postpartum supplements, or use hair oils, make sure to check the label for ingredients that breastfeeding sources flag:
- Ashwagandha: LactMed says it "should be avoided, especially while nursing a newborn or preterm infant."
- Saw palmetto, pumpkin seed oil, and rosemary oil: the 2025 NYU review lists all three (the first two as pills, rosemary oil on the scalp) as not recommended while breastfeeding, with more data needed.
- Theanine (found in Nutrafol Postpartum): LactMed says it is "probably best to avoid" theanine supplements while nursing a newborn or preterm baby.
Red light therapy caps: related evidence, minimal risks
A red light therapy cap shines light onto your scalp. Light isn't a substance, meaning that nothing enters your blood, and nothing stays on your skin to rub off on your baby's cheek.
For hair, a 2025 review that gathered 38 studies found that people with pattern hair loss who used red light regrew more hair than those who used sham devices. Additionally, two trials that tested only women found the same (one, two). However, those trials come with caveats. Primarily, they tested impact on pattern hair loss, the hereditary kind, not postpartum hair loss. Also, device makers paid for both, and for most of the trials in the review. Still, the AAD called the results for at-home caps "promising" and research continues.
LactMed lists laser therapy and phototherapy (including red light therapy) as "acceptable during breastfeeding," and the 2025 NYU dermatology review lists low-level laser therapy (red light therapy) as compatible with breastfeeding.
Our page on whether red light therapy is safe while breastfeeding goes into more detail.
Weighing the risks
Every option except red light therapy puts chemicals into your body, and only minoxidil has strong hair recovery evidence to counteract the potential risk.
Whatever you choose, the CDC advises to tell your provider and your baby's provider about anything you take, including "vitamins, herbs, and over-the-counter products."
Trying red light therapy without buying a cap
While researchers have not yet tested red light therapy on postpartum hair loss, the evidence from related kinds of hair loss is promising. Lumeni rents red light therapy caps because we think you should be able to test red light therapy for yourself without needing to buy an expensive cap that you may need for only a few months. Most customers use our caps for three to six months, depending on how fast they recover, and save 50-75% over the cost of buying one. Lumeni's rentals are also rent-to-own, so if you decide to keep your cap, 100% of the rent you've paid counts toward the purchase price through Lumeni.
Was this post useful?
Sources
- American Academy of Dermatology: Hair loss in new moms (https://www.aad.org/public/diseases/hair-loss/insider/new-moms); Hair loss: diagnosis and treatment (https://www.aad.org/public/diseases/hair-loss/treatment/diagnosis-treat); Supplement myths (https://www.aad.org/news/supplements-debunking-common-myths)
- Hirose et al. 2023, survey of 331 postpartum women in Tokyo, International Journal of Women's Dermatology: https://pmc.ncbi.nlm.nih.gov/articles/PMC10846762/
- LactMed (NIH): the database (https://www.ncbi.nlm.nih.gov/books/NBK501922/); Minoxidil (https://www.ncbi.nlm.nih.gov/books/NBK501032/); Phototherapy (https://www.ncbi.nlm.nih.gov/books/NBK500880/); Withania (ashwagandha) (https://www.ncbi.nlm.nih.gov/books/NBK501905/); Theanine (https://www.ncbi.nlm.nih.gov/books/n/lactmed/theanine/)
- e-lactancia (APILAM): Minoxidil (https://e-lactancia.org/breastfeeding/minoxidil/product/); Biotin (https://e-lactancia.org/breastfeeding/biotin-vitamin-b7-vitamin-h/product/)
- Needle et al. 2025, review of hair-loss treatments while breastfeeding, NYU Grossman School of Medicine, International Journal of Dermatology: https://pubmed.ncbi.nlm.nih.gov/40629555/
- HCPLive news summary, July 14, 2025: https://www.hcplive.com/view/safety-considerations-highlighted-for-alopecia-treatments-during-breastfeeding
- FDA labels on DailyMed: Propecia (https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f904709-65aa-44ce-b144-b4c8a0416e36); Minoxidil tablets, Par (https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f3800f0-b6da-4dfe-8c32-39bb5eb0262a); Women's Rogaine 2% solution (https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bf0000c-95f3-4a4d-830b-f5ac1539823d); Women's Rogaine 5% foam (https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4d328537-b7f5-43cc-9837-c5a0c6c390f8)
- Akiska et al. 2025, consensus of 43 hair loss dermatologists on low-dose oral minoxidil, JAMA Dermatology: https://pubmed.ncbi.nlm.nih.gov/39565602/
- Price et al. 2000, finasteride vs placebo in 137 postmenopausal women, Journal of the American Academy of Dermatology: https://pubmed.ncbi.nlm.nih.gov/11050579/
- Almohanna et al. 2019, review of vitamins and minerals in hair loss, Dermatology and Therapy: https://pmc.ncbi.nlm.nih.gov/articles/PMC6380979/
- Yelich et al. 2024, review of biotin for hair loss, Journal of Clinical and Aesthetic Dermatology: https://pmc.ncbi.nlm.nih.gov/articles/PMC11324195/
- Dang et al. 2026, six-month study of four Nutrafol formulas, paid for by the maker, Dermatology and Therapy: https://pmc.ncbi.nlm.nih.gov/articles/PMC13558537/
- Perez et al. 2025, review of 38 studies of red light for hair loss, Dermatologic Surgery: https://pubmed.ncbi.nlm.nih.gov/39404126/
- Lanzafame et al. 2014, red light helmet vs sham device in 42 women with pattern hair loss, Lasers in Surgery and Medicine: https://pubmed.ncbi.nlm.nih.gov/25124964/
- Friedman and Schnoor 2017, laser cap vs sham device in 40 women with pattern hair loss, Dermatologic Surgery: https://pubmed.ncbi.nlm.nih.gov/28328705/
- CDC: Prescription medication use while breastfeeding: https://www.cdc.gov/breastfeeding/breastfeeding-special-circumstances/vaccinations-medications-drugs/prescription-medication-use.html
- Vendor page (what the company says, not a finding): Nutrafol Postpartum (https://nutrafol.com/hair/women/product/core/postpartum/)